What is LQDA's current stock price?

LQDA (Liquidia Corporation) is currently trading at $60.29 with a market cap of $5.36B.

What sector is Liquidia Corporation in?

Liquidia Corporation (LQDA) operates in the Healthcare sector, specifically in the Biotechnology industry.

Is LQDA a good stock to buy?

Analysts have a Buy consensus on LQDA with a price target of $63.00. Check our detailed analysis for valuation, financials, and insider activity.

InvestLog

LQDA Liquidia Corporation

Healthcare

$60.29+0.00%OpenMarket Cap: $5.36B

As of 2026-05-26

Valuation

View Details

P/E (TTM)

—

PEG

—

P/B

49.43

P/S

18.82

EV/EBITDA

103.51

DCF Value

$-98.78

FCF Yield

0.8%

Div Yield

0.0%

Margins & Returns

Gross Margin

91.8%

Operating Margin

15.8%

Net Margin

7.7%

ROE

46.8%

ROA

5.6%

ROIC

12.8%

Financials

View All

Period	Revenue	Net Income	EPS
Q1 null	$132.9M	$52.9M	$—
Q4 null	$92.0M	$14.6M	$—
FY null	$158.3M	$-68.9M	$—
Q3 null	$54.3M	$-3.5M	$—

Analyst Ratings

View All

Consensus

Buy

Target (Consensus)

$63.00

Target (Median)

$62.00

Target Range

$60.00 - $67.00

1 Strong Buy7 Buy0 Hold1 Sell0 Strong Sell

Trading Activity

Insider Trades

View All

JEFFS ROGERdirector, officer: Chief Executive Officer

SellWed May 20

Caligan Partners LPdirector, 10 percent owner, other: See Remarks

SellWed May 20

Caligan Partners LPdirector, 10 percent owner, other: See Remarks

BuyWed May 20

JEFFS ROGERdirector, officer: Chief Executive Officer

SellFri May 15

Bloch Stephen Mdirector

SellWed May 13

Related AI Research

8-K EventMay 11, 2026

LQDA files 8-K — Item 2.02 Results of Operations

Liquidia Corporation (LQDA), a $3.

Company Info

Sector

Healthcare

Industry

Biotechnology

Country

Exchange

—

Beta

0.42

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil injection in the United States. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina.

Peers